Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara D Alexander

Showing results (51-60 of 142) with videos related to

Pageof 15
Sort By:
Journal of Fungi (Basel, Switzerland)|December 27, 2024
Real-World Antifungal Therapy Patterns Across the Continuum of Care in United States Adults with Invasive AspergillosisBarbara D Alexander, Melissa Johnson, Mark Bresnik, et al.
Clinical Microbiology Reviews|February 12, 2026
Fungal diagnostic stewardship in immunocompromised populations: a focus on molds and dimorphic fungiJulie M Steinbrink, Daniel Z Friedman, George R Thompson, et al.
Open Forum Infectious Diseases|January 20, 2025
Association Between the Need to Change Initial Antifungal Therapy and Treatment Costs in Patients With Invasive AspergillosisBarbara D Alexander, Melissa Johnson, Mark Bresnik, et al.
Open Forum Infectious Diseases|February 6, 2024
Risk Factors for Invasive Fungal Infection in Lung Transplant Recipients on Universal Antifungal ProphylaxisJonathan P Huggins, David Arthur, Shein-Chung Chow, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 12, 2021
Guidance on Imaging for Invasive Pulmonary Aspergillosis and Mucormycosis: From the Imaging Working Group for the Revision and Update of the Consensus Definitions of Fungal Disease from the EORTC/MSGERCBarbara D Alexander, Frédéric Lamoth, Claus Peter Heussel, et al.
Journal of Clinical Microbiology|December 1, 2006
Burkholderia glumae infection in an infant with chronic granulomatous diseaseJason B Weinberg, Barbara D Alexander, Joseph M Majure, et al.
Mycoses|July 11, 2022
Real-world effectiveness of antifungal prophylaxis with posaconazole as the primary agent in patients with haematological malignanciesAndrew M Strand, Barbara D Alexander, Eric Sarpong, et al.
American Journal of Medical Quality : the Official Journal of the American College of Medical Quality|January 10, 2025
Is Pathogen Molecular Testing Reshaping Outpatient Antibiotic Prescribing?Barbara D Alexander, William D Irish, Adriana E Rosato, et al.
Infection Control and Hospital Epidemiology|July 11, 2007
Risk factors for Burkholderia cepacia complex bacteremia among intensive care unit patients without cystic fibrosis: a case-control studyAdam M Bressler, Keith S Kaye, John J LiPuma, et al.
Journal of Clinical Microbiology|January 5, 2007
Comparative evaluation of Etest and sensititre yeastone panels against the Clinical and Laboratory Standards Institute M27-A2 reference broth microdilution method for testing Candida susceptibility to seven antifungal agentsBarbara D Alexander, Terry C Byrne, Kelly L Smith, et al.
Pageof 15

Showing results (51-60 of 142) with videos related to

Sort By:
Pageof 15
Journal of Fungi (Basel, Switzerland)|December 27, 2024
Real-World Antifungal Therapy Patterns Across the Continuum of Care in United States Adults with Invasive AspergillosisBarbara D Alexander, Melissa Johnson, Mark Bresnik, et al.
Clinical Microbiology Reviews|February 12, 2026
Fungal diagnostic stewardship in immunocompromised populations: a focus on molds and dimorphic fungiJulie M Steinbrink, Daniel Z Friedman, George R Thompson, et al.
Open Forum Infectious Diseases|January 20, 2025
Association Between the Need to Change Initial Antifungal Therapy and Treatment Costs in Patients With Invasive AspergillosisBarbara D Alexander, Melissa Johnson, Mark Bresnik, et al.
Open Forum Infectious Diseases|February 6, 2024
Risk Factors for Invasive Fungal Infection in Lung Transplant Recipients on Universal Antifungal ProphylaxisJonathan P Huggins, David Arthur, Shein-Chung Chow, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 12, 2021
Guidance on Imaging for Invasive Pulmonary Aspergillosis and Mucormycosis: From the Imaging Working Group for the Revision and Update of the Consensus Definitions of Fungal Disease from the EORTC/MSGERCBarbara D Alexander, Frédéric Lamoth, Claus Peter Heussel, et al.
Journal of Clinical Microbiology|December 1, 2006
Burkholderia glumae infection in an infant with chronic granulomatous diseaseJason B Weinberg, Barbara D Alexander, Joseph M Majure, et al.
Mycoses|July 11, 2022
Real-world effectiveness of antifungal prophylaxis with posaconazole as the primary agent in patients with haematological malignanciesAndrew M Strand, Barbara D Alexander, Eric Sarpong, et al.
American Journal of Medical Quality : the Official Journal of the American College of Medical Quality|January 10, 2025
Is Pathogen Molecular Testing Reshaping Outpatient Antibiotic Prescribing?Barbara D Alexander, William D Irish, Adriana E Rosato, et al.
Infection Control and Hospital Epidemiology|July 11, 2007
Risk factors for Burkholderia cepacia complex bacteremia among intensive care unit patients without cystic fibrosis: a case-control studyAdam M Bressler, Keith S Kaye, John J LiPuma, et al.
Journal of Clinical Microbiology|January 5, 2007
Comparative evaluation of Etest and sensititre yeastone panels against the Clinical and Laboratory Standards Institute M27-A2 reference broth microdilution method for testing Candida susceptibility to seven antifungal agentsBarbara D Alexander, Terry C Byrne, Kelly L Smith, et al.
Pageof 15